Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

ADVERTISEMENT
In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

Opinion 26 Apr 2023

Can mRNA vaccines tackle multiple diseases?

Watch: Sigrid CEO talks about lifestyle diseases 

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

NTU Singapore opens microbiome research center to study obesity and chronic diseases

Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS

Opinion 11 Jul 2022

Precision medicine: the next big leap for metabolic disorders